Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
The Bamboo Works

One-Trick Pony Boan Biotech Files for Hong Kong IPO Into Tough Market

Key Takeaways:

  • Boan Biotechnology sells only one product so far and is facing stiff competition from other similar drugs
  • Luye Pharma bought Boan in 2020 and is taking it public at a time when markets are bearish
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.